Developmental Funds

发展基金

• 批准号: 10333284
• 负责人: RAPHAEL E. POLLOCK
• 金额: $ 63.95万
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-09-12 至 2025-11-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10333284
• 关键词: Abbreviations; Award; Biometry; Budgets; Cancer Biology; Cancer Center Support Grant; Cancer Control; Cancer Survivorship; Catchment Area; Chemoprevention; Clinical; Clinical Research; Clinical Treatment; Clinical Trials; Collaborations; Communities; Comparative Pathology; Comprehensive Cancer Center; Development; Engineering; Evaluation; Faculty; Faculty Recruitment; Flow Cytometry; Funding; Genomics; Goals; Grant; Growth; Guidelines; Hematologic Neoplasms; Immunooncology; Information Technology; Institutes; Intervention; Intramural Research Program; Investments; Medical center; Microscopy; Molecular Carcinogenesis; NCI Center for Cancer Research; Ohio; Oncology; Pediatric Hospitals; Peer Review; Pharmaceutical Chemistry; Population Sciences; Process; Proteomics; Research; Research Personnel; Research Priority; Research Project Grants; Research Support; Resource Development; Resource Sharing; Science; Seeds; Services; Solid Neoplasm; Strategic Planning; Surveys; Translational Research; Universities; Vision; animal imaging; base; biomedical informatics; cancer prevention; college; community partnership; digital imaging; early-career faculty; faculty support; innovation; leukemia; leukemia tissue bank; member; mid-career faculty; pathology imaging; programs; recruit; senior faculty; translational genomics; translational therapeutics

PROJECT SUMMARY – DEVELOPMENTAL FUNDS The OSUCCC has provided seed funding for faculty recruitment and shared resource development. During the current grant cycle, 17 faculty were recruited, 8 of which were at the associate or full professor level. These faculty were strategically recruited to all 5 research programs and most focus on research relevant to the OSUCCC catchment area. They span 5 different colleges, 10 different departments across the colleges, and include Nationwide Children’s Hospital. Developmental funds used to support these faculty was $1,937,467. These investigators received $32,567,789 in NCI funding and $35,813,889 total peer-review funding, yielding a return on investment from CCSG developmental funds of 18:1. For the current funding cycle, we also established two developing shared resources (permitted under the prior CCSG guidelines), which were the Solid Tumor Translational developing Shared Resource (STTdSR) and the Veterinary Clinical Research Support Developing Shared Resource (VCRSdSR). The STTdSR has matured and is now called the Clinical-Translational Science Shared Resource (CTSSR) to reflect more broad use to include investigators focused on hematological malignancies and population science, in addition to those doing solid tumor research. Funding for this shared resource is requested in the current CCSG application. The VCRSdSR remains a developing shared resource; however, this will be supported from institutional funds and no CCSG funding is requested. The Specific Aims for Developmental Funds are: 1) to expand innovative and high-impact science focused on our four strategic priorities: immuno-oncology, cancer engineering, translational genomics, and cancer prevention and survivorship; 2) to identify and recruit senior, midlevel and early career faculty whose scientific expertise targets relevant needs in the OSUCCC strategic plan and catchment area (CA); and, 3) to use a robust evaluation process and provide seed funding for research projects that are inter-programmatic collaborations and/or are community focused, leading to NCI funding at the R01- or P01-equivalent level. To achieve these aims, for the current application, funds are being requested for the recruitment of investigators (n=18) matched to the OSUCCC research priorities and programmatic and catchment area needs. The OSUCCC also is requesting funding to leverage our highly successful Pelotonia-funded pilot awards program, called the Intramural Research Program. This is an externally peer reviewed mechanism that prioritizes projects for funding based on scientific merit and research focused on our catchment area, with additional consideration for early stage investigators. CSSG pilot funding will specifically target synergistic projects spanning two or more research programs representing inter-programmatic collaborations, and/or or projects developing community partnerships (funding for new shared resources are requested in the Shared Resource Management budget). Developmental funds and the CCSG review process are a critical way that our university evaluates the impact of the OSUCCC and allows us to substantially leverage our ongoing and substantial institutional commitments.

项目概要-行政基金 OSUCCC为教师招聘和共享资源开发提供了种子资金。期间 在本赠款周期，征聘了17名教员，其中8名为副教授或正教授。这些 教师被战略性地招募到所有5个研究项目，大多数专注于与 OSUCCC集水区。他们跨越5个不同的学院，10个不同的部门横跨学院， 包括全国儿童医院。用于支持这些教师的发展资金为1 937 467美元。 这些研究人员获得了32，567，789美元的NCI资金和35，813，889美元的同行评审资金， CCSG发展基金的投资回报率为18：1。对于当前的融资周期，我们还建立了 两个开发共享资源（根据之前的CCSG指南允许），这是实体肿瘤 转化开发共享资源（STTdSR）与兽医临床研究支持开发 共享资源（VCRSdSR）。STTdSR已经成熟，现在被称为临床转化科学 共享资源（CTSSR），以反映更广泛的使用，包括专注于血液学的研究者 恶性肿瘤和人口科学，除了那些做实体瘤研究。供资共享 在当前CCSG应用程序中请求资源。VCRSdSR仍然是一个发展中的共享资源; 然而，这将由机构资金支持，不要求CCSG提供资金。具体目标 发展基金的目标是：1）扩大创新和高影响力的科学，重点是我们的四个战略 优先事项：免疫肿瘤学，癌症工程，翻译基因组学，癌症预防和 生存; 2）确定和招聘高级，中级和早期职业教师，其科学专长的目标 OSUCCC战略计划和集水区（CA）中的相关需求;以及3）使用可靠的评估 处理并提供种子资金的研究项目是跨计划合作和/或 以社区为重点，导致R 01或P01级的NCI资金。为了实现这些目标， 根据目前的申请，正在申请资金，用于征聘与调查员人数相匹配的调查员（n=18）。 OSUCCC研究优先事项和方案及集水区需求。OSUCCC还要求 资金，以利用我们非常成功的Pelotonia资助的试点奖励计划，称为校内研究 程序.这是一个外部同行审查机制，根据科学的 优点和研究集中在我们的集水区，与早期阶段的调查人员额外的考虑。 CSSG试点资金将专门针对跨越两个或更多研究项目的协同项目 代表方案间合作和/或发展社区伙伴关系的项目（供资 新的共享资源在共享资源管理预算中申请）。发展基金 和CCSG审查过程是我们大学评估OSUCCC影响的重要方式， 使我们能够充分利用我们正在进行的和实质性的机构承诺。